These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12467617)

  • 1. New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased In vitro metabolic stability.
    Kikuchi C; Suzuki H; Hiranuma T; Koyama M
    Bioorg Med Chem Lett; 2003 Jan; 13(1):61-4. PubMed ID: 12467617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor.
    Kikuchi C; Ando T; Watanabe T; Nagaso H; Okuno M; Hiranuma T; Koyama M
    J Med Chem; 2002 May; 45(11):2197-206. PubMed ID: 12014957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M; Hallett DJ; Goodacre S; Moyes C; Crawforth J; Sparey TJ; Patel S; Marwood R; Patel S; Thomas S; Hitzel L; O'Connor D; Szeto N; Castro JL; Hutson PH; MacLeod AM
    J Med Chem; 2001 May; 44(10):1603-14. PubMed ID: 11334570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
    J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.
    Crawforth J; Goodacre S; Maxey R; Bourrain S; Patel S; Marwood R; O'Connor D; Herbert R; Hutson P; Rowley M
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2701-3. PubMed ID: 11133072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV; Deshpande AD; Kambhampati R; Badange RK; Kota L; Daulatabad AV; Shinde AK; Ahmad I; Kandikere V; Jayarajan P; Dubey PK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):346-9. PubMed ID: 21134749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor.
    Kikuchi C; Nagaso H; Hiranuma T; Koyama M
    J Med Chem; 1999 Feb; 42(4):533-5. PubMed ID: 10052959
    [No Abstract]   [Full Text] [Related]  

  • 8. 1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT(7) receptor ligands.
    Isaac MB; Xin T; O'Brien A; St-Martin D; Naismith A; MacLean N; Wilson J; Demchyshyn L; Tehim A; Slassi A
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2451-4. PubMed ID: 12161155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended N-Arylsulfonylindoles as 5-HT₆ Receptor Antagonists: Design, Synthesis & Biological Evaluation.
    Vera G; Lagos CF; Almendras S; Hebel D; Flores F; Valle-Corvalán G; Pessoa-Mahana CD; Mella-Raipán J; Montecinos R; Recabarren-Gajardo G
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27537868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DR4004, a putative 5-HT(7) receptor antagonist, also has functional activity at the dopamine D2 receptor.
    Kogan HA; Marsden CA; Fone KC
    Eur J Pharmacol; 2002 Aug; 449(1-2):105-11. PubMed ID: 12163113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epiminocyclohepta[b]indole analogs as 5-HT6 antagonists.
    Henderson AJ; Guzzo PR; Ghosh A; Kaur J; Koo JM; Nacro K; Panduga S; Pathak R; Shimpukade B; Tan V; Xiang K; Wierschke JD; Isherwood ML
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1494-8. PubMed ID: 22290076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists.
    Isaac M; Slassi A; Xin T; MacLean N; Wilson J; McCallum K; Wang H; Demchyshyn L
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1719-21. PubMed ID: 10937732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and preliminary screening of novel 3-(2-N,N-dimethylaminoethylthio) indole derivatives as potential 5-HT(6) receptor ligands.
    Kambhampati R; Konda J; Reballi V; Shinde AK; Dubey PK; Nirogi RV
    J Enzyme Inhib Med Chem; 2008 Jun; 23(3):302-12. PubMed ID: 18569332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.
    Bernotas RC; Antane S; Shenoy R; Le VD; Chen P; Harrison BL; Robichaud AJ; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1657-60. PubMed ID: 20138763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists.
    Fletcher SR; Burkamp F; Blurton P; Cheng SK; Clarkson R; O'Connor D; Spinks D; Tudge M; van Niel MB; Patel S; Chapman K; Marwood R; Shepheard S; Bentley G; Cook GP; Bristow LJ; Castro JL; Hutson PH; MacLeod AM
    J Med Chem; 2002 Jan; 45(2):492-503. PubMed ID: 11784153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
    Holenz J; Mercè R; Díaz JL; Guitart X; Codony X; Dordal A; Romero G; Torrens A; Mas J; Andaluz B; Hernández S; Monroy X; Sánchez E; Hernández E; Pérez R; Cubí R; Sanfeliu O; Buschmann H
    J Med Chem; 2005 Mar; 48(6):1781-95. PubMed ID: 15771424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.
    Forbes IT; Douglas S; Gribble AD; Ife RJ; Lightfoot AP; Garner AE; Riley GJ; Jeffrey P; Stevens AJ; Stean TO; Thomas DR
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3341-4. PubMed ID: 12392747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities.
    Schaffhauser H; Mathiasen JR; Dicamillo A; Huffman MJ; Lu LD; McKenna BA; Qian J; Marino MJ
    Biochem Pharmacol; 2009 Oct; 78(8):1035-42. PubMed ID: 19549510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.